jsharpe

About Jenny Sharpe

This author has not yet filled in any details.
So far Jenny Sharpe has created 283 blog entries.

CIRS R&D Briefing 105 – HTA Landscape under the EU HTA Regulation

Baseline mapping of national HTA authorities across the EU and EEA The EU Health Technology Assessment Regulation (HTAR) has moved from policy to practice, with Joint Clinical Assessments (JCAs) [...]

2026-07-22T09:12:10+00:00July 22nd, 2026|Tags: , |

Comparative review of 10 HTA systems – Dai 2026

Overview Health technology assessment (HTA) plays a key role in supporting evidence-informed healthcare decision making, pricing, reimbursement, and coverage decisions worldwide. As countries seek to strengthen health policy and [...]

2026-07-22T08:06:00+00:00July 16th, 2026|Tags: |

Q2 2026 Newsletter

We are pleased to share the latest CIRS newsletter with you, providing an update on our recent activities, research outputs, and upcoming work across medicine regulation and HTA. 🔍In [...]

2026-06-30T10:27:34+00:00July 6th, 2026|

CIRS RD Briefing 106 – New drug approvals by six major authorities 2016-2025

Overview This R&D Briefing presents the Centre for Innovation in Regulatory Science (CIRS) annual analysis of new active substance (NAS) approvals by six major regulatory authorities: the European Medicines [...]

CIRS RD Briefing 104 – Class 1 Innovative Medicines Approved in China: An International Comparison

As pharmaceutical innovation becomes increasingly global, companies are pursuing multi-jurisdictional approvals and timely patient access through evolving regulatory and reimbursement pathways. In China, regulatory reforms and expanded use of [...]

2026-05-13T09:41:56+00:00May 13th, 2026|Tags: , , |
Go to Top